Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?


OverviewForecastRevenueFinancialsChart

Stoke Therapeutics Ownership Summary


Stoke Therapeutics is owned by 33.73% institutional investors, 4.67% insiders, and 61.60% retail investors. Skorpios trust is the largest institutional shareholder, holding 12.26% of STOK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.97% of its assets in Stoke Therapeutics shares.

STOK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockStoke Therapeutics33.73%4.67%61.60%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Skorpios trust6.91M12.26%$76.18M
Blackrock5.41M11.70%$73.08M
Blackrock funding, inc. /de5.89M10.45%$64.94M
Lynx1 capital management lp5.19M9.21%$57.21M
Rtw investments, lp4.22M9.14%$57.08M
Baker bros. advisors lp4.63M8.22%$51.11M
Redmile group4.59M8.15%$50.67M
Morgan stanley3.48M7.52%$47.00M
Cowen and company3.37M7.28%$45.47M
Toronto dominion bank3.17M5.63%$35.00M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Skorpios trust6.91M99.80%$76.18M
Lynx1 capital management lp5.19M21.45%$57.21M
Redmile group4.59M3.53%$50.67M
Birchview capital, lp210.00K1.89%$2.32M
Checkpoint capital305.39K1.71%$3.37M
Cowen and company3.37M1.25%$45.47M
Bioimpact capital685.83K1.07%$7.56M
Siren2.00M0.97%$22.06M
Exome asset management113.10K0.94%$1.25M
Rtw investments, lp4.22M0.88%$57.08M

Top Buyers

HolderShares% AssetsChange
Toronto dominion bank3.17M0.06%3.17M
Siren2.00M0.97%2.00M
Blackrock5.41M0.00%1.55M
State street1.59M0.00%1.01M
Blackrock funding, inc. /de5.89M0.00%317.36K

Top Sellers

HolderShares% AssetsChange
Skorpios trust6.91M99.80%-2.00M
Healthcare of ontario pension plan trust fund---1.39M
Logos global management lp---1.05M
Marshall wace, llp951.43K0.01%-719.30K
Morgan stanley3.48M0.00%-546.21K

New Positions

HolderShares% AssetsChangeValue
Toronto dominion bank3.17M0.06%3.17M$35.00M
Siren2.00M0.97%2.00M$22.06M
Norges bank314.80K0.00%314.80K$3.47M
Tang capital management300.00K0.22%300.00K$3.31M
Schonfeld strategic advisors291.80K0.02%291.80K$3.22M

Sold Out

HolderChange
Quest partners-2.00
Nelson, van denburg & campbell wealth management group-5.00
Lindbrook capital-30.00
Capital performance advisors llp-32.00
Quarry lp-118.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202438-68.33%19,005,198-67.36%330.32%20-67.21%10-72.22%
Sep 30, 20241203.45%58,218,197-5.03%1030.59%61-25.61%3663.64%
Jun 30, 20241165.45%61,304,73913.13%1320.97%8217.14%22-15.38%
Mar 31, 202411032.53%54,189,69220.45%1171.17%70112.12%26-18.75%
Dec 31, 202383-17.00%44,987,6322.40%1001.02%33-23.26%32-11.11%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.61M2.97%-
Vanguard Total Stock Mkt Idx Inv1.57M2.91%-
iShares Russell 2000 ETF952.40K1.76%-8.25K
BlackRock Health Sciences Opps Inv A925.94K1.71%-
BGF World Healthscience A2851.11K1.57%-
SPDR® S&P Biotech ETF755.95K1.40%-8.10K
Vanguard Institutional Extnd Mkt Idx Tr593.53K1.10%1.08K
BlackRock Health Sciences Term Trust530.09K1.00%-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc414.93K0.79%14.31K
Fidelity Small Cap Index355.25K0.66%-6.65K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 18, 2025Kaye Edward M. MD-Sell$90.01K
Mar 19, 2025Kaye Edward M. MD-Sell$73.66K
Mar 19, 2025Ticho Barry CHIEF MEDICAL OFFICERSell$27.56K
Mar 18, 2025Ticho Barry CHIEF MEDICAL OFFICERSell$33.67K
Mar 18, 2025Allan Jonathan GENERAL COUNSEL & CORP SECSell$19.65K

Insider Transactions Trends


DateBuySell
2025 Q1-6
2024 Q4-11
2024 Q3-7
2024 Q2-11
2024 Q1-10

STOK Ownership FAQ


Who Owns Stoke Therapeutics?

Stoke Therapeutics shareholders are primarily institutional investors at 33.73%, followed by 4.67% insiders and 61.60% retail investors. The average institutional ownership in Stoke Therapeutics's industry, Biotech Stocks , is 68.48%, which Stoke Therapeutics falls below.

Who owns the most shares of Stoke Therapeutics?

Stoke Therapeutics’s largest shareholders are Skorpios trust (6.91M shares, 12.26%), Blackrock (5.41M shares, 11.70%), and Blackrock funding, inc. /de (5.89M shares, 10.45%). Together, they hold 34.40% of Stoke Therapeutics’s total shares outstanding.

Does Blackrock own Stoke Therapeutics?

Yes, BlackRock owns 11.70% of Stoke Therapeutics, totaling 5.41M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 73.08M$. In the last quarter, BlackRock increased its holdings by 1.55M shares, a 40.19% change.

Who is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested?

Skorpios trust is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested, with 99.80% of its assets in 6.91M Stoke Therapeutics shares, valued at 76.18M$.

Who is the top mutual fund holder of Stoke Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Stoke Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.61M Stoke Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools